Healthcare-associated infections (HAIs) during the coronavirus disease 2019 (COVID-19) pandemic: A time-series analysis.
Journal
Antimicrobial stewardship & healthcare epidemiology : ASHE
ISSN: 2732-494X
Titre abrégé: Antimicrob Steward Healthc Epidemiol
Pays: England
ID NLM: 9918266096106676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
29
09
2022
revised:
10
11
2022
accepted:
12
11
2022
entrez:
30
1
2023
pubmed:
31
1
2023
medline:
31
1
2023
Statut:
epublish
Résumé
To use interrupted time-series analyses to investigate the impact of the coronavirus disease 2019 (COVID-19) pandemic on healthcare-associated infections (HAIs). We hypothesized that the pandemic would be associated with higher rates of HAIs after adjustment for confounders. We conducted a cross-sectional study of HAIs in 3 hospitals in Missouri from January 1, 2017, through August 31, 2020, using interrupted time-series analysis with 2 counterfactual scenarios. The study was conducted at 1 large quaternary-care referral hospital and 2 community hospitals. All adults ≥18 years of age hospitalized at a study hospital for ≥48 hours were included in the study. In total, 254,792 admissions for ≥48 hours occurred during the study period. The average age of these patients was 57.6 (±19.0) years, and 141,107 (55.6%) were female. At hospital 1, 78 CLABSIs, 33 CAUTIs, and 88 VAEs were documented during the pandemic period. Hospital 2 had 13 CLABSIs, 6 CAUTIs, and 17 VAEs. Hospital 3 recorded 11 CLABSIs, 8 CAUTIs, and 11 VAEs. Point estimates for hypothetical excess HAIs suggested an increase in all infection types across facilities, except for CLABSIs and CAUTIs at hospital 1 under the "no pandemic" scenario. The COVID-19 era was associated with increases in CLABSIs, CAUTIs, and VAEs at 3 hospitals in Missouri, with variations in significance by hospital and infection type. Continued vigilance in maintaining optimal infection prevention practices to minimize HAIs is warranted.
Identifiants
pubmed: 36714284
doi: 10.1017/ash.2022.361
pii: S2732494X22003618
pmc: PMC9879893
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e14Informations de copyright
© The Author(s) 2023.
Références
BMC Med Res Methodol. 2006 Apr 03;6:16
pubmed: 16579864
Int J Epidemiol. 2013 Aug;42(4):1187-95
pubmed: 23760528
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
J Clin Pharm Ther. 2002 Aug;27(4):299-309
pubmed: 12174032
Infect Control Hosp Epidemiol. 2022 Jan;43(1):12-25
pubmed: 34473013
Antimicrob Resist Infect Control. 2021 Jun 4;10(1):87
pubmed: 34088341
Infect Control Hosp Epidemiol. 2022 Aug;43(8):1054-1057
pubmed: 33845927
Clin Infect Dis. 2022 May 30;74(10):1748-1754
pubmed: 34370014
Med Care. 2017 Jul;55(7):698-705
pubmed: 28498196
J Eval Clin Pract. 2018 Aug;24(4):695-700
pubmed: 29749091
Antimicrob Resist Infect Control. 2021 Aug 12;10(1):119
pubmed: 34384493
Infect Control Hosp Epidemiol. 2021 Nov;42(11):1372-1373
pubmed: 34766901
Antibiotics (Basel). 2021 Aug 09;10(8):
pubmed: 34439009